A promising molecule, called BT13, has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do.
Researchers from the University of Helsinki have found that molecule BT13 has the potential to both boost levels of dopamine, the chemical that is lost in Parkinson’s, as well as protecting the dopamine-producing brain cells from dying.
The results from the study, co-funded by Parkinson’s UK, showed an increase in dopamine levels in the brains of mice following treatment with the molecule. BT13 also activated a specific receptor in the mouse brains to protect the cells.
These findings suggest that BT13 could have the potential to lead to a new drug treatment that can slow, stop or even reverse the loss of brain cells in Parkinson’s.
Why is dopamine important?
Typically, by the time people are diagnosed with Parkinson’s, they have already lost 70-80 per cent of their dopamine-producing cells. These are involved in coordinating movement.
Current treatments mask the symptoms, but there is nothing that can slow down its progression or prevent more brain cells from being lost. As dopamine levels continue to fall, symptoms get worse and new symptoms can appear.
The role of BT13
Researchers are now working on improving the properties of BT13 to make it more effective as a potential treatment. If successful, this could benefit the 145,000 people living with Parkinson’s in the UK.
The study builds on previous research on another molecule that targets the same receptors in the brain, glial cell line-derived neurotrophic factor (GDNF), an experimental treatment for Parkinson’s which was the subject of a major clinical trial funded by Parkinson’s UK. While the results were not clear cut, GDNF has shown promise to restore damaged cells in Parkinson’s.
The GDNF protein requires complex surgery to deliver the treatment to the brain because it’s a large molecule. However BT13, a smaller molecule, could be more easily administered as a treatment if shown to be beneficial in further clinical trials.
“The molecule holds great promise”
Professor David Dexter, Deputy Director of Research at Parkinson’s UK, said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms.
“One of the biggest challenges for Parkinson’s research is how to get drugs past the blood-brain barrier, so the exciting discovery of BT13 has opened up a new avenue for research to explore.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Parkinson's Disease Treatment Market Valuable Growth Prospects, Size, Share, Demand and Current Trends Analysis 2026on June 1, 2020 at 7:25 am
Kenneth Research has published a detailed report on Parkinson's Disease Treatment Market which has been categorized ...
- Parkinson’s disease may spread from brain to gut and vice versaon May 31, 2020 at 11:07 pm
Research in baboons suggests that misfolded proteins linked to Parkinson’s disease can travel from the brain to gut and vice versa – with both routes causing equal amounts of brain cell death ...
- Molecular pair offers potential for Parkinson's treatmenton May 30, 2020 at 6:15 pm
A promising molecular pair has offered hope that could lead to the development of a new treatment to slow down Parkinson's disease, a study has found.
- The American Parkinson Disease association Vermont virtual optimism walk will raise funds to help people with Parkinson’s live life to the fulleston May 28, 2020 at 7:24 am
Together in Spirit, Vermont Residents Walk Separately to Help Provide More Programs and Services for the Local Parkinson’s Community BURLINGTON, VT, May 28, 2020 – The American Parkinson’s Disease ...
- Tag team of molecules boost motor function in Parkinson's studyon May 27, 2020 at 7:49 pm
The progression of Parkinson’s disease is tied to a compromised production of dopamine in the brain, so a great deal of research centers on techniques that can shore up supplies of the key ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Panel to work on finding out if trans-Pacific pact really beneficialon May 26, 2020 at 10:11 am
The Cabinet on Tuesday (May 26) assigned Digital Economy and Society Minister Buddhipongse Punnakanta the job of finding out whether Thailand should become part of the Comprehensive and Progressive ...
- Great food for staying at home: Restaurants across NI offering food and drink for delivery and collectionon May 21, 2020 at 1:00 am
Restaurants across Northern Ireland have adapted after they were forced to close due to the coronavirus pandemic, with many now offering meals, food kits, wine and cocktails for delivery and ...
- Hipshot BT13 Chromeon May 5, 2020 at 5:17 pm
This item is sold As-Described and cannot be returned unless it arrives in a condition different from how it was described or photographed. Items must be returned in original, as-shipped condition ...
- St James' Urban Farmon July 7, 2019 at 6:22 am
2nd Floor New Mill , Conway Mill , 5-7 Conway Street , Belfast , County Antrim , BT13 2DE , United Kingdom An existing piece of vacant green space at the end of the terraced streets was identified by ...